Rescinnamine

萝芙木碱

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRescinnamine
Drug Alias Name利血胺rescinaminarescinnamine利西那明rescinnaminum +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin-converting enzyme inhibitors
TargetsAngiotensin-converting enzyme
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1956/10/31
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeC02AA01
Related LinksWikipediaDrugBankKEGG